Matches in Wikidata for { <http://www.wikidata.org/entity/Q37512369> ?p ?o ?g. }
- Q37512369 description "article científic" @default.
- Q37512369 description "article scientifique" @default.
- Q37512369 description "articolo scientifico" @default.
- Q37512369 description "artigo científico" @default.
- Q37512369 description "artículu científicu espublizáu en 2017" @default.
- Q37512369 description "bilimsel makale" @default.
- Q37512369 description "scientific article published on January 2017" @default.
- Q37512369 description "vedecký článok" @default.
- Q37512369 description "vetenskaplig artikel" @default.
- Q37512369 description "videnskabelig artikel" @default.
- Q37512369 description "vědecký článek" @default.
- Q37512369 description "wetenschappelijk artikel" @default.
- Q37512369 description "wissenschaftlicher Artikel" @default.
- Q37512369 description "наукова стаття, опублікована в січні 2017" @default.
- Q37512369 description "научни чланак" @default.
- Q37512369 description "مقالة علمية نشرت في يناير 2017" @default.
- Q37512369 name "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 name "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 name "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 type Item @default.
- Q37512369 label "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 label "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 label "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 prefLabel "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 prefLabel "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 prefLabel "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 P1433 Q37512369-94E73B59-5B0A-4E3F-906A-538A640EE827 @default.
- Q37512369 P1476 Q37512369-4072EDDE-3B47-4F07-93C2-FF8EFBECF82A @default.
- Q37512369 P2093 Q37512369-4587C676-BD22-4FEF-8733-C494277E531D @default.
- Q37512369 P2093 Q37512369-47088BA9-8CEB-4676-B008-EAA5A915D6E1 @default.
- Q37512369 P2093 Q37512369-895EA9C6-0CD3-4C86-B633-F75CB4885CEA @default.
- Q37512369 P2093 Q37512369-96EFEFA5-FC64-4E2F-B364-3961D7E9BE51 @default.
- Q37512369 P2860 Q37512369-02A3B92C-2EC1-42CC-8355-223074A87565 @default.
- Q37512369 P2860 Q37512369-24675D0C-5B65-46FF-92D0-33307CAE858D @default.
- Q37512369 P2860 Q37512369-3066F71F-D8E6-43B1-BE80-2B0F7C2149C1 @default.
- Q37512369 P2860 Q37512369-30965150-88B4-4D4C-B7FB-A55D304ACDEF @default.
- Q37512369 P2860 Q37512369-62966232-45B8-4D09-AC93-4F398FC91D02 @default.
- Q37512369 P2860 Q37512369-836C9D39-38E8-4044-8D1D-1E14BC0853D2 @default.
- Q37512369 P2860 Q37512369-846E690B-E46B-4EE2-A40A-008B8494B7DA @default.
- Q37512369 P2860 Q37512369-9285F7E1-3AE9-4A3D-A21A-DFADB10B20EC @default.
- Q37512369 P2860 Q37512369-A0E7A25D-AA74-4EDA-BF94-4421A8FB972D @default.
- Q37512369 P2860 Q37512369-C02324D9-70FC-4B02-8038-FA8EA03A41E2 @default.
- Q37512369 P2860 Q37512369-C1C3BB43-5D44-4CDF-9549-A362D1368C48 @default.
- Q37512369 P2860 Q37512369-CF672F6F-FA50-4206-A47E-69D6988120C1 @default.
- Q37512369 P2860 Q37512369-D62F6CF5-E9C8-4784-BAA1-4C2F7BE83E67 @default.
- Q37512369 P2860 Q37512369-DF20AE84-4880-4EE8-A9C2-F1F307CDCA55 @default.
- Q37512369 P2860 Q37512369-E426858F-76B5-445D-A10D-07EC61A4AD5D @default.
- Q37512369 P2860 Q37512369-E87E4EDE-C664-466A-BEAE-044675A8381E @default.
- Q37512369 P2860 Q37512369-F7C6D4D6-C8EF-45E5-B7FE-C79DE1B2F732 @default.
- Q37512369 P2860 Q37512369-FD3CE0EC-AF0A-45A8-84A4-FE826A293E57 @default.
- Q37512369 P304 Q37512369-1A38EF81-A7E0-401C-8821-89662F90E3A7 @default.
- Q37512369 P31 Q37512369-74A47155-19BE-494B-A047-C8CCBA9DD8B0 @default.
- Q37512369 P356 Q37512369-1FD1760A-D073-4C43-A1C0-5D60B8027CE6 @default.
- Q37512369 P433 Q37512369-58328208-F876-48BD-9EF3-E6424336A41D @default.
- Q37512369 P478 Q37512369-EC62DBFE-3A0A-4324-803C-34FB7D2D47CF @default.
- Q37512369 P50 Q37512369-2B6FC031-85F7-4CBD-8DC6-78F6EFCC4E2C @default.
- Q37512369 P50 Q37512369-2BC93E65-6B8F-4264-8EF4-AE26D257F803 @default.
- Q37512369 P50 Q37512369-4160A33B-B1F0-457A-95D8-B3F599730E30 @default.
- Q37512369 P50 Q37512369-563CD3DC-0FEF-4F1F-A2BC-60F4474608A8 @default.
- Q37512369 P50 Q37512369-654814BD-1D92-40C6-A72B-CB2606135CB8 @default.
- Q37512369 P50 Q37512369-83B06540-2859-4E06-876B-6EA6C283EB5E @default.
- Q37512369 P50 Q37512369-89783E67-7B14-4C3D-B7CE-1123FEA7F922 @default.
- Q37512369 P50 Q37512369-97B59BE2-C3C9-495B-ADC7-9256FD5D20A4 @default.
- Q37512369 P50 Q37512369-C87EF596-E0B7-464F-9260-E84E4CB21278 @default.
- Q37512369 P50 Q37512369-D6266FB9-2B5E-4BA0-9672-DD5A1F29DE68 @default.
- Q37512369 P577 Q37512369-DA0415B9-7952-47CF-AFEC-DB57620093B6 @default.
- Q37512369 P698 Q37512369-17911F4D-1664-4D5C-A44B-1440F03F9F7D @default.
- Q37512369 P921 Q37512369-4110B2F3-D7BE-4945-92E9-60930E3280AD @default.
- Q37512369 P932 Q37512369-19C54256-C2F0-431B-93AE-33552EFCE3DE @default.
- Q37512369 P356 JGO.2017.28.E25 @default.
- Q37512369 P698 27958685 @default.
- Q37512369 P1433 Q26842232 @default.
- Q37512369 P1476 "Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study" @default.
- Q37512369 P2093 "Akira Yabuno" @default.
- Q37512369 P2093 "Eito Kozawa" @default.
- Q37512369 P2093 "Hiroyuki Yoshida" @default.
- Q37512369 P2093 "Tadaaki Nishikawa" @default.
- Q37512369 P2860 Q30300308 @default.
- Q37512369 P2860 Q33417673 @default.
- Q37512369 P2860 Q33898174 @default.
- Q37512369 P2860 Q34638316 @default.
- Q37512369 P2860 Q35180428 @default.
- Q37512369 P2860 Q36970765 @default.
- Q37512369 P2860 Q37601519 @default.
- Q37512369 P2860 Q38021752 @default.
- Q37512369 P2860 Q38262340 @default.
- Q37512369 P2860 Q38417643 @default.
- Q37512369 P2860 Q38587635 @default.
- Q37512369 P2860 Q40297293 @default.
- Q37512369 P2860 Q40826103 @default.
- Q37512369 P2860 Q41543671 @default.
- Q37512369 P2860 Q58964122 @default.
- Q37512369 P2860 Q73931798 @default.
- Q37512369 P2860 Q83313531 @default.
- Q37512369 P2860 Q86926092 @default.
- Q37512369 P304 "e25" @default.
- Q37512369 P31 Q13442814 @default.
- Q37512369 P356 "10.3802/JGO.2017.28.E25" @default.
- Q37512369 P433 "1" @default.
- Q37512369 P478 "28" @default.